- Home
- INSP vs IMNM Comparison
INSP vs IMNM Comparison
Compare INSP & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSP | IMNM |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | INSP | IMNM |
|---|---|---|
| Price | $79.64 | $26.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $133.07 | $31.22 |
| AVG Volume (30 Days) | 1.2M | ★ 2.1M |
| Earning Date | 02-11-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.77 | N/A |
| EPS | ★ 1.48 | N/A |
| Revenue | ★ $882,622,000.00 | $9,679,000.00 |
| Revenue This Year | $15.15 | N/A |
| Revenue Next Year | $10.98 | $11.53 |
| P/E Ratio | $53.79 | ★ N/A |
| Revenue Growth | ★ 16.81 | N/A |
| 52 Week Low | $70.77 | $5.15 |
| 52 Week High | $203.12 | $26.36 |
Technical Indicators
Market Signals| Indicator | INSP | IMNM |
|---|---|---|
| Relative Strength Index (RSI) | 32.12 | 72.07 |
| Support Level | $89.88 | $21.39 |
| Resistance Level | $97.52 | $22.01 |
| Average True Range (ATR) | 5.68 | 1.48 |
| MACD | -1.03 | 0.49 |
| Stochastic Oscillator | 7.43 | 95.84 |
Price Performance
Historical ComparisonAbout INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.